Savara (SVRA) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.02% |
| Dec 31, 2025 | -23.46% |
| Sep 30, 2025 | -5.69% |
| Jun 30, 2025 | -8.00% |
| Mar 31, 2025 | -10.45% |
| Dec 31, 2024 | -10.03% |
| Sep 30, 2024 | -15.60% |
| Jun 30, 2024 | -1.71% |
| Mar 31, 2024 | -6.35% |
| Dec 31, 2023 | -7.93% |
| Sep 30, 2023 | -8.48% |
| Jun 30, 2023 | -7.05% |
| Mar 31, 2023 | -6.20% |
| Dec 31, 2022 | -5.94% |
| Sep 30, 2022 | -20.26% |
| Jun 30, 2022 | -18.43% |
| Mar 31, 2022 | -70.73% |
| Dec 31, 2021 | -64.52% |
| Sep 30, 2021 | -61.57% |
| Jun 30, 2021 | -66.65% |
| Mar 31, 2021 | -52.30% |
| Dec 31, 2020 | -37.56% |
| Sep 30, 2020 | -23.97% |
| Jun 30, 2020 | -36.25% |
| Mar 31, 2020 | -30.32% |
| Dec 31, 2019 | -57.19% |
| Sep 30, 2019 | -32.54% |
| Jun 30, 2019 | -33.48% |
| Mar 31, 2019 | -28.65% |
| Dec 31, 2018 | -33.97% |
| Sep 30, 2018 | -29.95% |
| Jun 30, 2018 | -6.95% |
| Mar 31, 2018 | -21.57% |
| Dec 31, 2017 | -20.90% |
| Sep 30, 2017 | -5.96% |
| Jun 30, 2017 | -7.25% |
| Mar 31, 2017 | 25.65% |
| Dec 31, 2016 | 23.40% |
| Sep 30, 2016 | 16.53% |
| Jun 30, 2016 | 19.64% |
| Mar 31, 2016 | 12.76% |
| Dec 31, 2015 | 9.82% |
| Sep 30, 2015 | -1.89% |
| Jun 30, 2015 | 7.40% |